CN102342918A - 结肠靶向包衣系统、结肠靶向口服制剂及其制备方法 - Google Patents
结肠靶向包衣系统、结肠靶向口服制剂及其制备方法 Download PDFInfo
- Publication number
- CN102342918A CN102342918A CN2011101388504A CN201110138850A CN102342918A CN 102342918 A CN102342918 A CN 102342918A CN 2011101388504 A CN2011101388504 A CN 2011101388504A CN 201110138850 A CN201110138850 A CN 201110138850A CN 102342918 A CN102342918 A CN 102342918A
- Authority
- CN
- China
- Prior art keywords
- coating
- mixture
- preparation
- colon
- porogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 183
- 239000011248 coating agent Substances 0.000 title claims abstract description 109
- 238000002360 preparation method Methods 0.000 title claims abstract description 63
- 239000000203 mixture Substances 0.000 claims abstract description 70
- 229920002907 Guar gum Polymers 0.000 claims abstract description 29
- 229920001202 Inulin Polymers 0.000 claims abstract description 29
- 239000000665 guar gum Substances 0.000 claims abstract description 29
- 235000010417 guar gum Nutrition 0.000 claims abstract description 29
- 229960002154 guar gum Drugs 0.000 claims abstract description 29
- 229940029339 inulin Drugs 0.000 claims abstract description 29
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 29
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000000661 sodium alginate Substances 0.000 claims abstract description 28
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 28
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 210000000936 intestine Anatomy 0.000 claims description 41
- 238000000034 method Methods 0.000 claims description 41
- 239000003361 porogen Substances 0.000 claims description 30
- 239000006187 pill Substances 0.000 claims description 17
- 235000010603 pastilles Nutrition 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 13
- 238000012545 processing Methods 0.000 claims description 13
- 229920002301 cellulose acetate Polymers 0.000 claims description 12
- 238000004090 dissolution Methods 0.000 claims description 12
- 239000004014 plasticizer Substances 0.000 claims description 9
- 239000001856 Ethyl cellulose Substances 0.000 claims description 8
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 8
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 8
- 229920001249 ethyl cellulose Polymers 0.000 claims description 8
- 239000000945 filler Substances 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 239000008188 pellet Substances 0.000 claims description 5
- 239000004925 Acrylic resin Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 238000007796 conventional method Methods 0.000 claims description 3
- 239000000306 component Substances 0.000 claims description 2
- 239000002826 coolant Substances 0.000 claims description 2
- 230000002101 lytic effect Effects 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 230000009885 systemic effect Effects 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 19
- 210000001072 colon Anatomy 0.000 abstract description 17
- 229940079593 drug Drugs 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000011247 coating layer Substances 0.000 abstract 4
- 239000011148 porous material Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 230000000052 comparative effect Effects 0.000 description 10
- 239000000872 buffer Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 229920003137 Eudragit® S polymer Polymers 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 3
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 3
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 3
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 229930014456 matrine Natural products 0.000 description 3
- 108010070915 orgotein Proteins 0.000 description 3
- 229960004534 orgotein Drugs 0.000 description 3
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000007779 soft material Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- TUGDLVFMIQZYPA-UHFFFAOYSA-N tetracopper;tetrazinc Chemical compound [Cu+2].[Cu+2].[Cu+2].[Cu+2].[Zn+2].[Zn+2].[Zn+2].[Zn+2] TUGDLVFMIQZYPA-UHFFFAOYSA-N 0.000 description 3
- 239000001069 triethyl citrate Substances 0.000 description 3
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 3
- 235000013769 triethyl citrate Nutrition 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- 229920003136 Eudragit® L polymer Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 210000001815 ascending colon Anatomy 0.000 description 2
- 239000007931 coated granule Substances 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- OTQCKZUSUGYWBD-BRHMIFOHSA-N lepirudin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)[C@@H](C)O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C1=CC=C(O)C=C1 OTQCKZUSUGYWBD-BRHMIFOHSA-N 0.000 description 2
- 229960004408 lepirudin Drugs 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000000643 oven drying Methods 0.000 description 2
- 239000003961 penetration enhancing agent Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000003384 transverse colon Anatomy 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
剂型种类 | 外包衣层 | 基础赋形剂 |
片剂 | PVP(K30)、醋酸纤维素 | 淀粉(填充剂)、硬脂酸镁(润滑剂) |
胶囊剂 | PVP(K30)、醋酸纤维素 | 淀粉(填充剂)、微粉硅胶(润滑剂) |
滴丸 | PVP(K30)、醋酸纤维素、PEG400 | PEG4000、PEG6000(基质) |
微丸 | PVP(K30)、醋酸纤维素、PEG400 | 淀粉(填充剂) |
样品 | 瓜尔豆胶∶海藻酸钠∶菊粉 |
1 | 1∶0∶0 |
2 | 0∶1∶0 |
3 | 0∶0∶1 |
4 | 0∶1∶1 |
5 | 1∶0∶1 |
6 | 1∶1∶0 |
7 | 1∶1∶1 |
8 | 1∶2∶2 |
9 | 2∶2∶1 |
10 | 1∶3∶3 |
11 | 1∶4∶4 |
Claims (17)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110138850 CN102342918B (zh) | 2011-05-26 | 2011-05-26 | 结肠靶向包衣系统、结肠靶向口服制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110138850 CN102342918B (zh) | 2011-05-26 | 2011-05-26 | 结肠靶向包衣系统、结肠靶向口服制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102342918A true CN102342918A (zh) | 2012-02-08 |
CN102342918B CN102342918B (zh) | 2013-02-13 |
Family
ID=45542248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110138850 Active CN102342918B (zh) | 2011-05-26 | 2011-05-26 | 结肠靶向包衣系统、结肠靶向口服制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102342918B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104519876A (zh) * | 2012-08-27 | 2015-04-15 | 赢创工业集团股份有限公司 | 具有持续释放特征的和具有对乙醇影响的抗性的药物或保健品组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1582903A (zh) * | 2004-06-11 | 2005-02-23 | 沈阳药科大学 | 酶降解依赖型结肠定位释药柱塞胶囊及其制备方法 |
CN101214229A (zh) * | 2007-12-29 | 2008-07-09 | 天津大学 | 双层包衣的结肠靶向口服制剂及其制备方法 |
CN101669950A (zh) * | 2009-09-28 | 2010-03-17 | 南方医科大学 | 苦豆碱在制备治疗溃疡性结肠炎药物中的应用 |
-
2011
- 2011-05-26 CN CN 201110138850 patent/CN102342918B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1582903A (zh) * | 2004-06-11 | 2005-02-23 | 沈阳药科大学 | 酶降解依赖型结肠定位释药柱塞胶囊及其制备方法 |
CN101214229A (zh) * | 2007-12-29 | 2008-07-09 | 天津大学 | 双层包衣的结肠靶向口服制剂及其制备方法 |
CN101669950A (zh) * | 2009-09-28 | 2010-03-17 | 南方医科大学 | 苦豆碱在制备治疗溃疡性结肠炎药物中的应用 |
Non-Patent Citations (2)
Title |
---|
TIWARI AKANKSHA,ET AL.: "Natural Polymer in Colon Targeting", 《INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CLINICAL RESEARCH》 * |
胡万杨等: "口服结肠靶向制剂中辅料的应用", 《中国实验方剂学杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104519876A (zh) * | 2012-08-27 | 2015-04-15 | 赢创工业集团股份有限公司 | 具有持续释放特征的和具有对乙醇影响的抗性的药物或保健品组合物 |
US10842752B2 (en) | 2012-08-27 | 2020-11-24 | Evonik Operations Gmbh | Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol |
Also Published As
Publication number | Publication date |
---|---|
CN102342918B (zh) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0502032B1 (en) | Delayed release formulations | |
KR101767288B1 (ko) | 복용 용이성 고형 제제 | |
ES2452265T3 (es) | Composiciones para la administración oral de corticosteroides | |
US20030175355A1 (en) | Fast melt multiparticulate formulations for oral delivery | |
JP2004532257A (ja) | 高水溶性薬剤のテイスト・マスキング | |
CN101987081A (zh) | 一种控释制剂 | |
CN103006612B (zh) | 一种赖诺普利迟释缓释片剂及其制备方法 | |
CN101502491B (zh) | 一种地红霉素肠溶制剂 | |
CN101028274A (zh) | 治疗肝胆疾病的熊去氧胆酸制剂及其制备方法 | |
CN102349870A (zh) | 一种红霉素及其相关药物的新制剂及其制备方法 | |
CN107982241B (zh) | 一种炎琥宁肠溶制剂及制备方法 | |
CN108938601A (zh) | 一种盐酸二甲双胍肠溶缓释微丸及其制备方法 | |
JP3833314B2 (ja) | 発泡性組成物およびその製造方法 | |
CN102342918B (zh) | 结肠靶向包衣系统、结肠靶向口服制剂及其制备方法 | |
CN102552171B (zh) | 一种穿心莲内酯结肠定位微丸及其制备方法 | |
CN107982240B (zh) | 一种可精准溶出的炎琥宁肠溶颗粒及制备方法 | |
CN101120931A (zh) | 一种苯扎贝特缓释组合物 | |
CN102362874B (zh) | 水蛭结肠靶向口服制剂及其制备方法 | |
CN102223879A (zh) | 制备活性组分颗粒的新方法及所获得的颗粒 | |
EP2046306B1 (en) | Coating composition comprising starch | |
CN102579363B (zh) | 一种结肠定位释药的微丸及其制备方法 | |
CN103622930B (zh) | 一种盐酸二甲双胍缓释制剂及其制备方法 | |
WO2009101657A1 (ja) | 時限放出製剤 | |
CN101366946B (zh) | 淀粉基结肠靶向特异性粘附材料及其制备方法和应用 | |
CN102600103B (zh) | 一种结肠定位释药的胶囊壳及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: CHONGQING DUOPUTAI PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: CHONGQING SHIZHENGE PUSHENG PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Cao Jia Dian 400800 Chongqing city Wansheng District East Qingxi Bridge Patentee after: CHONGQING DUOPUTAI PHARMACEUTICAL Co.,Ltd. Address before: Cao Jia Dian 400800 Chongqing city Wansheng District East Qingxi Bridge Patentee before: Chongqing Duoputai Pharmaceutical Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Cao Jia Dian 400800 Chongqing city Wansheng District East Qingxi Bridge Patentee after: CHONGQING DUOPUTAI PHARMACEUTICAL Co.,Ltd. Address before: Cao Jia Dian 400802 Chongqing city Wansheng District Chongqing Donglin Qingxi bridge shizhenge Epson Pharmaceutical Co. Ltd. Patentee before: CHONGQING SHIZHENGE PUSHENG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240115 Address after: No. 303-7, Qingxi Bridge, Donglin Street, Wansheng Economic Development Zone, Qijiang District, Chongqing, 400800 Patentee after: Chongqing Duoputai Pharmaceutical Technology Co.,Ltd. Address before: 400800 Donglin Qingxi bridge in Wansheng District, Chongqing Patentee before: CHONGQING DUOPUTAI PHARMACEUTICAL Co.,Ltd. |